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Summary
 
Ship is an Src homology 2 domain containing inositol polyphosphate 5-phosphatase which has
been implicated as an important signaling molecule in hematopoietic cells. In B cells, Ship be-
comes associated with Fc
 
g
 
 receptor IIB (Fc
 
g
 
RIIB), a low affinity receptor for the Fc portion of
immunoglobulin (Ig)G, and is rapidly tyrosine phosphorylated upon B cell antigen receptor
 
(BCR)–Fc
 
g
 
RIIB coligation. The function of Ship in lymphocytes was investigated in Ship
 
2
 
/
 
2
 
recombination-activating gene (Rag)
 
2
 
/
 
2
 
 chimeric mice generated from gene-targeted Ship
 
2
 
/
 
2
 
embryonic stem cells. Ship
 
2
 
/
 
2
 
Rag
 
2
 
/
 
2
 
 chimeras showed reduced numbers of B cells and an
overall increase in basal serum Ig. Ship
 
2
 
/
 
2
 
 splenic B cells displayed prolonged Ca
 
2
 
1
 
 influx,
increased proliferation in vitro, and enhanced mitogen-activated protein kinase (MAPK) acti-
vation in response to BCR–Fc
 
g
 
RIIB coligation. These results demonstrate that Ship plays an
essential role in Fc
 
g
 
RIIB-mediated inhibition of BCR signaling, and that Ship is a crucial neg-
ative regulator of Ca
 
2
 
1
 
 flux and MAPK activation.
Key words: inositol phosphatase • Fc
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S
 
hip is
 
 
 
an inositol polyphosphate 5-phosphatase that hydro-
lyzes phosphatidylinositol-3,4,5-polyphosphate (PIP3)
 
1
 
and inositol-1,3,4,5-polyphosphate (IP4; references 1 and
2). The catalytic domain of Ship has been shown to reduce
the intracellular PIP3 levels and to inhibit the biological ef-
fects induced by phosphatidylinositol 3
 
9
 
-kinase activation
in 
 
Xenopus
 
 oocytes (3). In addition to the catalytic domain,
Ship contains an Src homology (SH)2 domain, three puta-
tive SH3 interacting motifs, and two potential phosphoty-
rosine binding (PTB) domain binding sites. Ship can inter-
act with membrane receptors (4, 5), tyrosine kinases (6),
and adapter proteins (7, 8). It has been suggested that Ship
functions as a negative regulator of cell growth (2) and as a
positive factor in cellular apoptosis (9).
Immune complexes consisting of antigen and IgG anti-
bodies are potent inhibitors of humoral immune responses
(10). The immune complex–mediated inhibition of anti-
body production depends on the coligation of the antigen-
specific B cell antigen receptor (BCR) and Fc
 
g
 
RIIB, a low
affinity receptor for the Fc portion of IgG (11). Engage-
ment of the BCR in the absence of coligation induces
rapid activation of tyrosine kinases, generation of inositol
phosphates, elevation of the cytoplasmic Ca
 
2
 
1
 
 concentra-
tion, and mitogen-activated protein kinase (MAPK) activa-
tion (12). These events result in cellular activation and lead
to B cell proliferation, differentiation, and antibody secre-
tion (13). In contrast, coligation of the BCR and Fc
 
g
 
RIIB
leads to inhibition of the extracellular Ca
 
2
 
1
 
 influx (14), re-
duction of cell proliferation (15), and blockage of blasto-
genesis (16).
Fc
 
g
 
RIIB delivers the inhibitory signal to downstream
SH2-containing proteins through its immunoreceptor ty-
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell antigen receptor; ERK, ex-
tracellular signal–regulated protein kinase; ES, embryonic stem; FBS, fetal
bovine serum; Grb, growth factor receptor–bound protein; HSA, heat
stable antigen; ICAM, intracellular adhesion molecule; IP4, inositol-
1,3,4,5-polyphosphate; ITIM, immunoreceptor tyrosine–based inhibitory
motif; JNK, c-Jun NH
 
2
 
-terminal kinase; MAPK, mitogen-activated pro-
tein kinase; PIP3, phosphatidylinositol-3,4,5-polyphosphate; Rag, re-
combination-activating gene; SAPK, stress-activated protein kinase; SH,
Src homology domain; Ship, SH2-containing inositol polyphosphate
5-phosphatase; SHP, SH2-containing protein tyrosine phosphatase; VSV,
vesicular stomatitis virus.
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B Cell Abnormalities in Ship
 
2
 
/
 
2
 
Rag
 
2
 
/
 
2
 
 Mice
 
rosine–based inhibitory motif (ITIM), a 13–amino acid
sequence that is tyrosine phosphorylated in response to
BCR and Fc
 
g
 
RIIB coligation (17). Several SH2-contain-
ing molecules bind to the ITIM of Fc
 
g
 
RIIB (18), includ-
ing the SH2-containing tyrosine phosphatase SHP-1 (19)
and the phosphatidylinositol phosphatase Ship (4).
 
 
 
SHP-1
was thought to play a significant role in Fc
 
g
 
RIIB signaling
(15). However, recent studies have shown that SHP-1 is
dispensable for Fc
 
g
 
RIIB-mediated inhibition of mast cell
degranulation (4) and BCR-triggered Ca
 
2
 
1
 
 influx (20),
suggesting that SHP-1 is not involved in the early signaling
events of Fc
 
g
 
RIIB inhibition. Another candidate for a key
role in Fc
 
g
 
RIIB-mediated inhibition is the Ship protein.
Ship interacts with the ITIM of Fc
 
g
 
RIIB (4) and is rapidly
tyrosine phosphorylated in response to BCR–Fc
 
g
 
RIIB
coligation (21, 22). Deletion of Ship in a chicken B cell
line rendered the cells resistant to Fc
 
g
 
RIIB-mediated inhi-
bition of Ca
 
2
 
1
 
 accumulation (23), suggesting a direct in-
volvement of Ship in the Fc
 
g
 
RIIB pathway.
To determine the function of Ship in B and T lympho-
cytes in vivo, we generated embryonic stem (ES) cell lines
with a homozygous mutation in the 
 
Ship
 
 gene and Ship
 
2
 
/
 
2
 
Rag
 
2
 
/
 
2
 
 chimeric mice. Ship
 
2
 
/
 
2
 
Rag
 
2
 
/
 
2
 
 mice had reduced
numbers of B cells, but increased basal serum Igs. Ship
 
2
 
/
 
2
 
 B
lymphocytes exhibited prolonged Ca
 
2
 
1
 
 influx and increased
proliferation upon BCR–Fc
 
g
 
RIIB coligation, demonstrat-
ing an essential requirement for Ship in Fc
 
g
 
RIIB-mediated
negative signaling. Furthermore, MAPK activation in Ship
 
2
 
/
 
2
 
B cells was increased after BCR–Fc
 
g
 
RIIB coligation, sug-
gesting that, once recruited to Fc
 
g
 
RIIB, Ship can act as a
negative regulator of MAPK signaling.
 
Materials and Methods
 
Generation of Ship
 
2
 
/
 
2
 
Rag-1
 
2
 
/
 
2
 
 Mice.
 
A 129/J mouse genomic
library was screened with a 300-bp probe which contained the
translational initiation codon of the 
 
Ship
 
 gene. Positive clones
were characterized by restriction mapping and sequence analysis
to determine intron–exon structure and the translation initiation
site. A targeting construct was created by first cloning the coding
sequences of the
 
 LacZ
 
 gene in-frame with the ATG codon of 
 
Ship
 
,
and then replacing the rest of the 
 
Ship
 
 ATG–containing exon and
part of the following intron with a 
 
neo
 
 cassette. A thymidine ki-
nase expression unit was also included for negative selection (24).
The linearized targeting vector was electroporated into the 129/
Ola-derived ES cell line E14, and colonies were selected in G418
(150 
 
m
 
g/ml; GIBCO BRL, Gaithersburg, MD) and gancyclovir
(2 
 
m
 
M/ml; see pp. 33–62 in reference 25). Doubly resistant clones
were expanded and DNA samples were digested with HindIII and
hybridized to a 3
 
9
 
 external probe to identify recombinants. 4 out of
384 cell lines were heterozygous at the 
 
Ship
 
 locus. DNA from these
lines was digested with EcoRV and hybridized to a 5
 
9
 
 HindIII-
HindIII internal probe to check for multiple 
 
neo
 
 insertion events.
All Ship
 
1
 
/
 
2
 
 ES cell lines contained a single 
 
neo
 
 integration. Two
independent heterozygous 
 
Ship 
 
clones were cultured at increased
concentrations of G418 (1.5 mg/ml) to select for homozygous
mutants. Approximately 50% of the surviving clones exhibited
homozygous mutation of the 
 
Ship
 
 gene. A parental Ship
 
1
 
/
 
2
 
 and
three independent Ship
 
2
 
/
 
2
 
 ES cell clones were injected into
Rag-1
 
2
 
/
 
2
 
 blastocysts. All four ES cell lines contributed to the re-
constitution of T and B cell compartments in Rag-1–deficient
mice, and all three Ship
 
2
 
/
 
2
 
Rag2/2 chimeric mouse strains were
similar in phenotype. Mice were maintained at the animal facili-
ties of the Ontario Cancer Institute in accordance with institu-
tional guidelines.
Flow Cytometry. The following FITC-conjugated, PE-conju-
gated, or biotinylated antibodies were used for flow cytometry:
anti-FcgRII/III (clone 2.4G2), anti–TCR-a/b (clone H57-
597), anti-CD3e (clone 145-2C11), anti-CD4 (clone H129.19),
anti-CD8a (clone 53-6.7), anti-B220 (clone RA3-6B2), anti-
IgDb (clone 217-170), anti-IgM (clone R6-60.2), anti-CD43
(clone S7), anti-CD19 (clone 1D3), anti-CD25 (clone 7D4),
anti-CD24 (anti–heat stable antigen [HSA], clone M1/69), anti-
CD40 (clone HM40-3), anti-CD44 (clone 1M7), anti-CD95
(clone Jo2), anti–intracellular adhesion molecule (ICAM)-1 (clone
3E2) (all from PharMingen, San Diego, CA). Biotinylated antibod-
ies were visualized using Streptavidin-Red670 (GIBCO BRL).
Spleen, thymus, lymph node, and bone marrow cells were pre-
pared for flow cytometry according to standard procedures (26).
In brief, 2 3 105 cells were incubated at 48C for 30 min in stain-
ing buffer (PBS containing 1% fetal bovine serum [FBS]) with
saturating amounts of antibodies against lineage-specific surface
antigens. Cells were washed with staining buffer and incubated
with streptavidin-Red670 at 48C for another 30 min. After wash-
ing with staining buffer, cells were analyzed using a FACSCali-
burÒ flow cytometer and CELLQuest software (Becton Dickin-
son, Mountain View, CA).
In Vitro B Cell Proliferation. Splenic lymphocytes from 8–14-
wk-old mice were incubated in 0.155 M ammonium chloride,
0.1 mM sodium EDTA, 0.1% potassium bicarbonate, pH 7.3, for
5 min on ice to lyse red blood cells. Cells were washed with PBS
and incubated with anti–Thy-1, anti-CD8, and anti-CD4 in
combination with rabbit complement (Cedarlane Labs Ltd.,
Hornby, Ontario, Canada) for complement-mediated lysis of T
cells. Lymphocytes were collected from the interface of a lym-
pholyte purification gradient (Lympholyte-M; Cedarlane Labs
Ltd.). The purity of each of the splenic B cell preparations was
verified by flow cytometric analysis, and was typically $85%.
Purified splenic B cells (5 3 104/100 ml) were cultured in trip-
licate in RPMI medium supplemented with 5% FBS, 2 mM so-
dium pyruvate, 1 mM glutamine, 50 mM b-mercaptoethanol, and
antibiotics at 378C for 3 h. Goat anti–mouse IgM (Jackson Im-
munoResearch Laboratories, West Grove, PA), the F(ab9)2 frag-
ment of goat anti–mouse IgM (Jackson ImmunoResearch Labora-
tories), LPS (Sigma Chemical Co., St. Louis, MO), or anti-CD40
antibody was added to the culture medium at various concentra-
tions. Cells were incubated in triplicate for 48–72 h followed by
the addition of 1 mCi/well [3H]thymidine (Nycomed Amersham
plc, Little Chalfont, Bucks, UK). Cells were harvested 6 h after
thymidine addition, and the amount of [3H]thymidine incorpora-
tion was determined using a b-scintillation counter (Coulter
Corp., Miami, FL).
In Vitro T Cell Proliferation. Freshly isolated lymphocytes from
lymph nodes were placed into round-bottomed 96-well plates
(Fisher Scientific, Nepean, Ontario, Canada) in RPMI medium
supplemented with 5% FBS, 2 mM sodium pyruvate, 1 mM
glutamine, 50 mM b-mercaptoethanol, and antibiotics. Cells
were activated with PMA (10 mg/ml) plus Ca21 ionophore
A23617 (100 ng/ml), soluble anti-CD3e (0.2 mg/ml, clone 145-
2C11, hamster IgG; PharMingen), and soluble anti-CD28 (0.02
mg/ml and 0.2 mg/ml, clone 37.51, hamster IgG; PharMingen)
in triplicate for 48 h followed by the addition of [3H]thymidine
and analysis as described above.1335 Liu et al.
Intracellular Ca21 Measurements. Splenocytes (5 3 106/ml)
were loaded with 3 mM Indo-1 (Molecular Probes, Inc., Eugene,
OR) at 378C for 1 h in IMDM supplemented with 2% FCS. Af-
ter washing with medium, cells were labeled with PE-conjugated
anti–TCR-a/b antibody to remove T cells by gating. B cells
were stimulated by the addition of intact rabbit anti–mouse IgG
(Zymed Laboratories, Inc., South San Francisco, CA) or the
F(ab9)2 fragment of rabbit anti–mouse IgG (Zymed Laboratories,
Inc.). Cells were stimulated with a titration series of each anti-
body to determine optimal conditions. Cytosolic Ca21 flux of 106
cells was recorded using a FACSVantageÒ (Becton Dickinson).
Ca21 mobilization from intracellular stores was measured in the
presence of 2 mM EGTA. Thymocytes (5 3 106/ml) were
loaded with 5 mM Indo-1 following the same procedure except
that cells were incubated with 5 mg/ml anti-CD3e or 5 mg/ml
anti-CD3e plus 1 mg/ml anti-CD28 in ice for 15 min, and Ca21
flux was recorded immediately after the addition of 30 mg/ml
anti–hamster IgG.
Western Blot Analysis. Purified splenic B cells (2 3 106 cells/
100 ml PBS) were stimulated with PBS alone, goat anti–mouse
IgM antibody (20 mg/ml), the F(ab9)2 fragment of goat anti–
mouse IgM (15 mg/ml), LPS (2 mg/ml), or anti-CD40 antibody
(5 mg/ml) at 378C for various time periods. At the end of the
stimulation, cells were immediately diluted with 1 ml ice-cold
PBS containing 1 mM sodium vanadate (Na3VO4), pelleted by
centrifugation, and resuspended in 20 ml ice-cold lysis buffer con-
sisting of 1% Triton X-100, 1% deoxycholate, 50 mM Hepes
buffer, pH 7.4, 150 mM NaCl, 10% glycerol, 1.5 mM MgCl2,
1 mM EGTA, 100 mM NaF, 1 mM PMSF, and 1 mM Na3VO4.
Cell debris was pelleted, and supernatants containing the whole
cell lysates were analyzed on 15% SDS–polyacrylamide gels at an
acrylamide to bis-acrylamide ratio of 120:1. Proteins were trans-
ferred to nitrocellulose membranes and immunoblotted with
phospho-specific P44/P42 MAPK antibody (Thr202/Tyr204;
New England Biolabs Inc., Beverly, MA) to reveal the presence
of activated MAPK; phospho-specific stress-activated protein ki-
nase (SAPK)/c-Jun NH2-terminal kinase (JNK) antibody (New
England Biolabs Inc.) to reveal the presence of activated SAPK/
JNK; and phospho-specific IkB antibody (New England Biolabs
Inc.) to reveal nuclear factor kB activation. To verify equivalent
loading and to confirm the identity of the phosphorylated
MAPK, membranes were stripped with 100 mM b-mercaptoeth-
anol, 2% SDS, 62.5 mM Tris (pH 6.7) at 558C for 30 min and
blotted with anti–extracellular signal–regulated protein kinase
(ERK)2 antibody (Transduction Laboratories, Lexington, KY).
Immunoblots were visualized with enhanced chemiluminescence
detection reagents (ECL; Nycomed Amersham plc).
Freshly isolated thymocytes were incubated with 10 mg/ml of
rabbit anti–hamster IgG on ice for 15 min followed by stimula-
tion with anti-CD3e or anti-CD3e plus anti-CD28 at 378C for
various time periods (1–15 min). Activation was stopped by the
addition of ice-cold PBS containing 1 mM Na3VO4. Cells were
lysed and analyzed as described above.
Detection of Ig Levels. ELISA for Ig subclasses was performed
on serially diluted serum samples using anti–mouse Ig (IgG plus
IgA plus IgM) antibodies and alkaline phosphatase–conjugated
anti–mouse Ig isotype antibodies (Southern Biotechnology Asso-
ciates, Inc., Birmingham, AL) according to the manufacturer’s di-
rections.
Serum Neutralization Test. Vesicular stomatitis virus (VSV)
Indiana (Mudd-Summers isolate) seeds were grown on BHK21
cells infected with a low multiplicity of infection and plaqued on
Vero cells. Sera were collected from mice at defined time points
after VSV infection. The sera were prediluted 40-fold in MEM
containing 5% FCS and then heat-inactivated at 568C for 30 min.
Serial twofold dilutions were mixed with equal volume of VSV-
containing medium (500 PFU/ml) and incubated in a 5% CO2
incubator at 378C for 90 min. 100 ml of the mixture was trans-
ferred onto Vero cell monolayers in 96-well plates and incubated
at 378C for 1 h. The monolayers were then overlaid with 100 ml
of DMEM containing 1% methylcellulose. After incubating at
378C for 24 h, the monolayer was fixed and stained with 0.5%
crystal violet. The highest dilution of serum that reduced the
number of plaques by 50% was taken as titer. To determine IgG
titers, undiluted serum was pretreated with an equal volume of
0.1 mM b-mercaptoethanol in saline to eliminate IgM.
In Vitro Th Cell Differentiation. Splenocytes (2 3 106/ml) de-
pleted of red blood cells were cultured in duplicate in RPMI me-
dium supplemented with 5% FBS, 50 mM b-mercaptoethanol,
and 13 penicillin-streptomycin (GIBCO BRL), and were stimu-
lated with 10 mg/ml plate-bound anti-CD3e in the presence of 1
ng/ml IL-12 (PharMingen) for Th1 or 50 ng/ml IL-4 (PharMin-
gen) for Th2 differentiation. After 5 d incubation, cells were
washed in PBS, and an equal number of viable cells was replated
in 10 mg/ml plate-bound anti-CD3e in the absence of cytokine
addition. Supernatants were collected 24 h later, and the produc-
tion of IFN-g and TNF-a from Th1-differentiated or of IL-4
and IL-6 from Th2-differentiated cultures was measured in dupli-
cate by ELISA assay (Genzyme Corp., Cambridge, MA).
Results
Generation of Ship2/2Rag2/2 Chimeric Mice. Targeted in-
activation of the Ship gene in ES cells was accomplished
by replacement of the first coding exon and part of the fol-
lowing intron with the LacZ gene from Escherichia coli and
the gene encoding neomycin phosphotransferase (neo) (Fig.
1 A). Ship2/2 ES cells were isolated by selecting Ship1/2
ES cells in elevated levels of G418. Homozygous mutation
of the Ship gene was confirmed by Southern blot analysis of
genomic DNA (Fig. 1 B). Three different Ship2/2 clones
and a parental Ship1/2 ES cell clone were injected into
blastocysts from Rag-12/2 mice. Since Rag-deficient mice
do not produce any mature lymphocytes due to a block in
the initiation of V(D)J recombination (27), mature lym-
phocytes in the chimeric mice must be derived from the
injected ES cells. Chimeric mice were characterized by
flow cytometric analysis of CD41 and CD81 T cells and
IgD1 B cells in circulating blood. Genetic chimerism was
further substantiated by Southern blot analysis of DNA
obtained from tail biopsies (data not shown). Western blot
analysis of lysates prepared from thymocytes (data not
shown) and splenocytes (Fig. 1 C) of the Ship2/2Rag2/2
chimeras showed the absence of Ship protein, indicating
that the engineered Ship mutation was a null mutation. All
chimeric mice appeared healthy and had no apparent ab-
normalities.
Increased Numbers of Peripheral T cells, but Normal T Cell
Proliferation in Ship2/2Rag2/2 Mice. The thymus and lymph
nodes were of normal size in Ship2/2Rag2/2 chimeric
mice, but the spleen was significantly enlarged. The total
number of thymocytes and the percentages of CD42CD821336 B Cell Abnormalities in Ship2/2Rag2/2 Mice
pre-T cells and CD41CD81 immature T cells in Ship2/2
Rag2/2 mice were similar to those found in Ship1/2Rag2/2
mice (Table 1), showing that early thymic development
was normal. However, the ratio of mature CD41 to CD81
T cells was higher in Ship2/2Rag2/2 compared with Ship1/2
Rag2/2 chimeric mice, suggesting an effect of the mutation
on the progression of immature CD41CD81 thymocytes
to mature CD41 and CD81 T cells and/or CD4/CD8
homeostasis in peripheral lymphoid organs (Table 1). No
abnormalities were found in the surface expression levels of
TCR-a/b, CD3, CD28, or CD95 on either CD41 or
CD81 single positive thymocytes, CD41CD81 double
positive thymocytes, or peripheral T cells (data not shown).
To test the role of Ship in T cell proliferation, lymph
node T cells were stimulated in vitro with either anti-
CD3e antibody, anti-CD3e plus anti-CD28 antibodies,
Con A, or PMA plus Ca21 ionophore. No significant dif-
ferences in the extent or kinetics of proliferation or IL-2
production were observed between the Ship1/2 and Ship2/2
T cells (data not shown). Similarly, no obvious differences
were observed in the levels of phosphorylated IkB, MAPK,
or SAPK between Ship1/2 and Ship2/2 T cells after anti-
CD3e or anti-CD3e plus anti-CD28 stimulation (data not
shown). The extent and duration of Ca21 mobilization also
appeared to be normal in Ship2/2 thymocytes activated
with anti-CD3e or anti-CD3e plus anti-CD28 (data not
shown).
Reduced Numbers of B Cells in Ship2/2Rag2/2 Mice. To
examine the effect of the Ship mutation on B cell develop-
ment, single cell suspensions from spleen and bone marrow
of Ship1/2Rag2/2 and Ship2/2Rag2/2 chimeras were
stained with mAbs against B lineage–specific markers. The
bone marrow of Ship2/2Rag2/2 chimeric mice had normal
numbers of B2201CD431 pro-B cells but significantly re-
duced numbers of B2201sIgM1 immature and B2201sIgD1
mature B cells (Fig. 2, and Table 1), suggesting a partial
maturational defect of Ship2/2 B cells. We found that B
cell numbers were also reduced in the B2201sIgM2 popu-
lation that expresses the IL-2Ra chain (CD25; Table 1), an
early B cell maturation marker that appears in the small
pre-B stage before sIgM expression (28). Consistent with
this finding, Ship2/2Rag2/2 mice showed normal percent-
ages of B220loHSAhi large pre-B cells, but significantly
reduced percentages of the more mature B2201HSAlo pop-
ulation (Table 1). These results suggest that B cell produc-
tion is normal in Ship2/2Rag2/2 chimeric mice until the
B2201CD431 large pre-B stage, but fewer B cells were
present in the small pre-B and more mature populations.
Peripheral B cells from Ship2/2Rag2/2 chimeras ex-
pressed normal cell surface levels of CD19, CD40, CD44,
ICAM-1, and CD95, but reduced levels of CD23 (data not
shown). Closer examination of splenic B cell subpopula-
tions revealed a decrease in the sIgMhisIgDhi population
with a shift towards the more mature sIgMlosIgDhi pheno-
Figure 1. Gene targeting of
the Ship locus. (A) Targeting
vector. A 1-kb NcoI-BamHI
fragment was replaced by the
LacZ gene and the neomycin re-
sistance (neo) gene. The coding
sequence of the LacZ gene was
cloned in-frame with the Ship
ATG codon by using the NcoI
site immediately downstream of
the ATG codon. The HSV-tk
gene was appended to allow for
selection against random integra-
tion. 1.8 and 5 kb of homolo-
gous sequences flanking the re-
placement were retained. The
predicted structure of the dis-
rupted allele is shown. Black box,
The exon. Nt, Not1; B, BamHI;
N, NcoI; S, SmaI; K, KpnI; Bg,
BglII; H, HindIII; X, XhoI; E,
EcoRI. (B) Southern blot show-
ing homozygous Ship2/2 ES
cell lines created through selec-
tion of Ship1/2 lines in a high
concentration of G418. Ge-
nomic DNA from ES cells was
digested with EcoRV and
hybridized to a 59 internal probe
to visualize a 10.5-kb band for
the wild-type allele and a 5.8-kb
band for the mutant allele. (C)
Western blot analysis of Ship2/2 lymphocyte proteins. Protein extracts from 2 3 106 purified splenic B cells of Ship1/2Rag2/2 and Ship2/2Rag2/2 mice
were hybridized to anti-Ship antibody raised against amino acid residues 276–450 (reference 47). The position of Ship is indicated. The nitrocellulose
membrane was then stripped and rehybridized to anti-actin antibody to control for the amount of protein loaded in each lane.1337 Liu et al.
type (Fig. 2). This shift is probably not a consequence of
lowered sIgM expression due to the Ship mutation, since
the level of sIgM expression is normal in Ship2/2 B cells in
the bone marrow (Fig. 2). We favor the hypothesis that this
shift reflects an augmented maturational event occurring in
Ship2/2 B lymphocytes.
Higher Titers of Serum Ig and Normal Anti-VSV Response
of Ship2/2Rag2/2 Mice. To assess the functional conse-
quences of Ship deficiency, we analyzed the production of
Igs in Ship2/2Rag2/2 chimeric mice. Sera from unimmu-
nized Ship2/2Rag2/2 chimeras showed an overall increase
in Ig levels despite a reduction in the number of peripheral
B cells. In particular, IgM, IgA, IgG2a, and IgG2b levels
were elevated, whereas IgG1 levels were reduced (Fig. 3 A).
To further characterize the functional significance of the
Ship deficiency in vivo, chimeric mice were immunized
with VSV. Unexpectedly, antivirus-specific antibody pro-
duction occurred at a normal level and with similar kinetics
in the T help–independent neutralizing IgM response as
well as in T cell–dependent class switching from IgM to
IgG (29; Fig. 3 B). Moreover, similar titers of neutralizing
IgG were detected for both Ship1/2Rag2/2 and Ship2/2
Rag2/2 mice 80 d after immunization (Fig. 3 B, and data
not shown), although the levels of nonneutralizing Ig were
significantly higher in Ship2/2Rag2/2 chimeras (data not
shown). These results show that Ship is not essential to
maintain the homeostasis of VSV-neutralizing IgM and
IgG responses, and suggest that multiple negative signaling
molecules regulate in vivo B cell responses.
Normal Production of Th1 and Th2 Cytokines by Ship2/2 T
Cells. The reduced level of serum IgG1, an IL-4–driven
Ig isotype, and the increased level of IgG2a, which depends
on IFN-g for Ig class switching, suggested that Th cell dif-
ferentiation might be affected in Ship2/2 T cells. There-
fore, we examined the response of Ship2/2 T cells to two
different stimuli known to induce the differentiation of
Th1 and Th2 cells. Ship2/2 splenocytes stimulated with
anti-CD3e in the presence of IL-4, which induces Th2 dif-
ferentiation, showed normal levels of IL-4 and IL-6 pro-
duction. Similarly, when Ship2/2 T cells were stimulated
with anti-CD3e in the presence of IL-12, which induces
Th1 differentiation, there was no significant difference be-
tween Ship2/2 and Ship1/2 cells in the production of Th1-
type cytokines IFN-g and TNF-a (data not shown). Al-
though these results do not preclude a role of Ship in Th1
and Th2 cytokine production in vivo, our in vitro data im-
ply that Ship has no essential role in Th1 and Th2 lineage
differentiation.
Increased Proliferation of Ship2/2 B Cells upon BCR–Fcg-
RIIB Coligation. To test the hypothesis that Ship downregu-
lates B cell activation (23), B cell proliferation in Ship2/2
Rag2/2 chimeric mice was examined. BCR signaling can
be activated by the F(ab9)2 fragment of anti-IgM (or anti-
IgG) antibodies that cause cross-linking of sIgM (or sIgG;
reference 11). Intact antibodies fail to stimulate BCR-
mediated cellular activation because they coligate the BCR
and FcgRIIB (11), resulting in activation of the FcgRIIB
inhibitory pathway. When sIgM was cross-linked on puri-
fied Ship2/2 and Ship1/2 B cells using the F(ab9)2 fragment
of anti-IgM, comparable proliferative responses were in-
duced, suggesting that BCR signaling is normal in Ship2/2
B cells (Fig. 4). However, whereas coligation of sIgM and
FcgRIIB with intact anti-IgM did not significantly stimu-
late proliferation in Ship1/2 cells, Ship2/2 B cells prolifer-
ated just as strongly in response to intact antibody as they
had in response to anti-IgM F(ab9)2 stimulation (Fig. 4).
Similar, but less dramatic, results were obtained using anti–
mouse IgG (data not shown). No differences in prolifera-
tion were detected when Ship2/2 and Ship1/2 B cells were
stimulated with LPS or anti-CD40, agents that do not use
the FcgRIIB pathway (30, 31; Fig. 4 B). These results
show that Ship is required for the delivery of a negative
regulatory signal in response to BCR–FcgRIIB coligation.
Prolonged Ca21 Mobilization in Ship2/2 B Cells upon
BCR–FcgRIIB Coligation. A well-documented effect of
BCR and FcgRIIB coligation is the inhibition of extracel-
Table 1. T and B Cell Subpopulations in Ship2/2Rag2/2 
Chimeric Mice
Ship1/2Rag2/2 Ship2/2Rag2/2
Thymus
Total cell number (3 107)8   6  0.6 8.6 6 0.9
CD41CD81 (% 6 SEM) 81.5 6 4.1 76.6 6 4.9
CD41CD82 13.3 6 3.2 17.6 6 3.9
CD42CD81 2.3 6 1.0 2.8 6 0.8
CD42CD82 2.96 0.2 3.1 6 0.4
Lymph nodes
Total cell number (3 107) 2.4 6 0.6 2 6 0.5
CD41CD82 (% 6 SEM) 58.3 6 3.1 68.5 6 3.5
CD42CD81 17.8 6 2.8 13.4 6 2.5
Spleen
Total cell number (3 107) 6.5 6 0.4 11 6 1.2
CD41CD82 (% 6 SEM) 29.2 6 4.9 47.4 6 3.1
CD42CD81 13.8 6 2.0 9.4 6 4.8
B2201sIgM1 36 6 5.5 27 6 4.5
sIgD1sIgMhi 10.7 6 2.0 4.7 6 1.7
sIgDhisIgMlo 24.2 6 4.1 20 6 3.5
Bone marrow
Total cell number (3 107) 1.2 6 0.3 1.4 6 0.3
B2201CD431 (% 6 SEM) 8.5 6 3.3 9.8 6 2.4
BD2201CD432 45.4 6 4.6 19.1 6 2.9
B2201CD251IgM2 7.1 6 1.4 4.5 6 1.0
B220loHSAhi 26.4 6 4.2 25.3 6 2.6
B2201HSAlo 16 6 3.1 4.9 6 1.2
B2201sIgM1 16.4 6 2.1 8.7 6 2.5
Cells from Ship1/2 (n 5 5) and Ship2/2 (n 5 7) chimeric mice were
stained with the indicated antibodies, and populations were determined
using a FACScanÒ. Bold numbers, Statistically significant differences
between Ship1/2 and Ship2/2 subpopulations.1338 B Cell Abnormalities in Ship2/2Rag2/2 Mice
lular Ca21 influx (14, 20, 23). To determine whether Ship
acts by downregulating the Ca21 influx associated with
BCR stimulation, we compared Ca21 mobilization in
Ship1/2 and Ship2/2 B lymphocytes after sIg activation or
sIg–FcgRIIB coligation. Ship1/2 B cells activated with the
F(ab9)2 fragment of anti-IgG exhibited a rapid increase in
intracellular free Ca21 (Fig. 5 B), a response that was re-
duced in Ship1/2 B cells stimulated with intact anti-IgG
antibody. In contrast, an increased and prolonged Ca21 re-
sponse was observed in Ship2/2 B cells stimulated with in-
tact anti-IgG antibody (Fig. 5 B), despite normal FcgRIIB
expression on the cell surface (Fig. 5 A). This increased
Ca21 response to intact anti-IgG could be normalized to
the level observed in Ship1/2 B cells by the addition of the
Ca21 chelator EGTA, which exhausts the extracellular
Ca21 store (data not shown). These data suggest that Ship
acts as negative regulator in the FcgRIIB pathway by con-
trolling the Ca21 influx.
Enhanced ERK2 Phosphorylation in Ship2/2 B Cells upon
BCR–FcgRIIB Coligation. BCR signaling has also been
shown to activate the ERK2 isoform of MAPKs (32, 33).
This activation is accompanied by an increase in phosphor-
ylation of ERK2 (34). To test whether Ship is involved in
the MAPK pathway, we examined ERK2 phosphorylation
after BCR activation. As shown in Fig. 6, ERK2 was acti-
vated equally in Ship1/2 and Ship2/2 B cells in response to
anti-IgM F(ab9)2 stimulation. As expected, ERK2 phos-
phorylation was reduced in Ship1/2 B cells when the BCR
Figure 2. Flow cytometric analysis of
lymphocytes from Ship2/2Rag2/2 chi-
meric mice. Total lymphocytes from bone
marrow and spleen were stained with lin-
eage-specific antibodies as indicated.
Boxes, Percentages of distinct subpopula-
tions of B cells. One result representative
of five different experiments is shown.
Figure 3. (A) Increased basal serum Ig levels in Ship2/2Rag-12/2 mice. Unimmunized Ship1/2Rag-12/2 and Ship2/2Rag-12/2 mice were bled at 8–18
wk of age, and concentrations of serum Ig isotypes were determined by isotype-specific ELISAs. Results from six pairs of experimental mice are shown.
(B) Normal neutralizing IgM and IgG levels in Ship2/2 Rag-12/2 mice after VSV infection. Ship1/2Rag-12/2 (1/-) and Ship2/2Rag-12/2 (2/2) mice
were infected intraperitoneally with VSV, and VSV-neutralizing IgM and IgG titers were determined after infection at the indicated time intervals.
Results are representative of six experimental pairs of animals.1339 Liu et al.
and FcgRIIB were coligated by intact anti-IgM. In con-
trast, Ship2/2 B cells showed no reduction in ERK2 phos-
phorylation after intact anti-IgM stimulation, suggesting
that Ship plays a role in the downregulation of the MAPK
pathway, and that the MAPK pathway is involved in the
delivery of the FcgRIIB inhibitory signal.
Discussion
Ship is an inositol phosphatase that plays important roles
in signal transduction (5, 20, 23). To investigate Ship’s
function in lymphocytes, we generated Ship-deficient ES
cell lines through homologous recombination, and created
Ship2/2Rag2/2 chimeric mice. Our analyses of Ship2/2
Rag2/2 chimeras show that Ship is required for immune
complex–mediated inhibition of B cell proliferation and
the regulation of antibody production. In addition, al-
though the primary function of Ship appears to be one of
negative regulation of BCR signaling, our studies suggest
that Ship is also involved in pre-B cell maturation and ho-
meostasis of T cell subsets.
The inactivation of Ship in B lymphocytes resulted in
enhanced proliferation in response to BCR and FcgRIIB
coligation by intact anti-Ig, indicating that FcgRIIB-medi-
Figure 4. Enhanced prolifera-
tive responses of Ship2/2 B cells to
anti-IgM stimulation. (A) Purified
splenic B cells were cultured with
the indicated amounts of intact
goat anti–mouse IgM or of goat
anti–mouse IgM F(ab9)2 for 48 h.
(B) Purified splenic B cells were in-
cubated with 20 mg/ml goat anti–
mouse IgM, 15 mg/ml goat anti–
mouse IgM F(ab9)2, 2 mg/ml LPS,
or 5 mg/ml anti-CD40 for 60 h.
Proliferation was assessed by the
incorporation of [3H]thymidine.
Mean [3H]thymidine uptake 6 SD
of triplicate cultures of Ship1/2
and Ship2/2 B cells is shown. Re-
sults are representative of three in-
dependent experiments.
Figure 5. Prolonged Ca21 flux in Ship2/2 B cells. (A) FcgRIIB expression on B cells. Histogram indicates the expression of FcgRIIB on B cell popu-
lations. FcgRIIB was stained with anti-FcgRII/III antibody 2.4G2 (solid lines). Broken line, Negative staining with anti-Ship antibody. (B) Ca21 mobiliza-
tion. Indo-1–labeled splenocytes were stimulated with 10 mg/ml rabbit anti–mouse IgG or 5 mg/ml rabbit anti–mouse IgG F(ab9)2. Arrows, Time point
of antibody addition. Results representative of three independent experiments are shown.1340 B Cell Abnormalities in Ship2/2Rag2/2 Mice
ated inhibition of BCR signaling is Ship dependent. Ship2/2
B cells did not show any defects in other signaling path-
ways that bypass FcgRIIB, such as stimulation by F(ab9)2,
anti-CD40, or LPS; therefore, the predominant role of
Ship in resting B cells appears to be confined to the
FcgRIIB pathway. We have also noticed that the prolifera-
tive responses of Ship2/2 B cells to intact anti-Ig were very
similar to that of F(ab9)2 stimulation, whereas B cells from
me/me mice (which are SHP-1–deficient) had a prolifera-
tive response to intact anti-Ig stimulation at 40% of their
response to F(ab9)2 activation (15). Thus, although SHP-1
may be involved, Ship is the predominant signaling mole-
cule downstream of FcgRIIB.
In B cells, BCR–FcgRIIB coligation triggers molecular
events that lead to the inhibition of the Ca21 influx nor-
mally initiated by BCR activation, resulting in reduction of
BCR signaling (23). In this study, we have shown that the
deletion of Ship abrogates FcgRIIB-mediated inhibition of
Ca21 influx in B cells. Interestingly, the extent and dura-
tion of Ca21 mobilization that occurred in response to
BCR–FcgRIIB coligation in the absence of Ship were sig-
nificantly increased over the Ca21 influx observed in re-
sponse to BCR activation. Since the prolonged Ca21
mobilization was clearly associated with BCR–FcgRIIB
coligation, we speculate that other signaling molecules may
be interacting with the phosphorylated ITIM of FcgRIIB
in the absence of Ship, and that these interactions generate
signals leading to a delayed closing of the membrane Ca21
channels. For example, the phosphorylated ITIM of FcgRIIB
has been shown to be an ideal docking site for several SH2-
containing proteins, some of which might indirectly mod-
ulate Ca21 mobilization (15, 18, 19).
An interesting question is whether modulation of Ca21
mobilization is the sole function of Ship in FcgRIIB signal-
ing. It has been shown that the catalytic domain alone of
Ship is capable of delivering the inhibitory effect mediated
by FcgRIIB, suggesting direct involvement of the Ship
substrates IP4 and/or PIP3 in this signaling process (23).
Since IP4 is able to activate the cytoplasmic membrane
Ca21 channels (35), it has been postulated that the ITIM of
FcgRIIB, once phosphorylated after BCR–FcgRIIB coli-
gation, recruits Ship to the membrane, where it hydrolyzes
IP4 and brings the membrane Ca21 channels to a closed
state (23, 36). Our results indicate that this is probably not
the only function of Ship in delivering FcgRIIB signal,
since the MAPK ERK2 was found to be hyperphosphory-
lated in Ship2/2 B cells after BCR–FcgRIIB coligation.
We speculate that, once recruited to the membrane and ty-
rosine phosphorylated, Ship may also modulate the extent
of BCR-triggered MAPK signaling through interaction
with molecules involved in the BCR pathway. A well-
documented interacting partner for Ship is the adapter pro-
tein Shc (22, 37). BCR signaling induces the tyrosine
phosphorylation of Shc and the subsequent formation of
Shc–growth factor receptor–bound protein (Grb)2–Sos
complexes, which mediate Ras and MAPK activation (38,
39). However, BCR–FcgRIIB coligation appear to en-
hance the formation of Ship–Shc complexes and to reduce
Shc–Grb2 interaction (37), suggesting that Ship may down-
regulate the MAPK pathway by competing with Grb2 for
Shc binding (40).
Another candidate molecule that may link Ship to BCR
signaling is the BCR coreceptor CD19. CD19 becomes
rapidly tyrosine phosphorylated after engagement of the
BCR (41), but is dephosphorylated upon BCR–FcgRIIB
coligation (42, 43). Furthermore, CD19-deficient B cells
were unable to respond to FcgRIIB-mediated inhibition
(44). Although it is not clear at this point how an inositol
phosphatase like Ship could regulate the dephosphorylation
of tyrosines in CD19, it is conceivable that Ship is instru-
mental in the formation of a multiprotein signal transduc-
ing complex. It is possible that one component protein of
the complex could be a tyrosine phosphatase; for example,
Ship has been shown to associate with SHP-2 in hemato-
poietic cell lines (45).
Although Ship was found to interact with the immuno-
receptor tyrosine activation motifs (ITAMs) from the CD3
complex and TCR z chain in vitro (46), normal prolifera-
tion, IL-2 production, MAPK and SAPK phosphorylation,
and Ca21 mobilization were detected in Ship2/2 T cells after
TCR activation. These findings indicate that Ship is probably
not involved in TCR signaling. However, the elevation in
the ratio of CD41 to CD81 single positive cells in Ship2/2
Rag2/2 mice, in conjunction with the upregulation of Ship
expression in single positive thymocytes after positive selec-
tion (47), suggests that Ship plays a role in mature T cells.
The effect of Ship deficiency appeared to be more dra-
matic in B cells. We observed a significant reduction of the
percentage of B2201CD251sIgM2 small pre-B cells in
Ship2/2Rag2/2 chimeric mice. These early B cell popula-
tions do not yet express sIgM, suggesting a role of Ship be-
sides inhibition of BCR signaling. The role of Ship in early
B cell maturation and the receptor(s) for signaling mole-
cules on which Ship acts during pre-B cell differentiation
need to be determined. The percentages of premature
IgM1 and mature IgD1 B cells were also reduced in bone
marrow and peripheral immune organs. This reduction is
not caused by a defect in cell proliferation, because Ship2/2
B cells showed enhanced proliferative response toward in-
tact antibody stimulation and normal responses toward LPS
and anti-CD40 activation (Fig. 4). Since B cells go through
negative selection during maturation to assure immunolog-
Figure 6. Increased ERK2 phosphorylation in Ship2/2 B cells by anti-
IgM stimulation. Antiphospho-MAPK immunoblot of whole cell lysates
of purified splenic B cells stimulated with 20 mg/ml goat anti–mouse
IgM, or 15 mg/ml F(ab9)2 goat anti–mouse IgM, at 378C for the indicated
time period (in minutes). Membranes were stripped and rehybridized to
anti-ERK2 antibody to control for loading between lanes. One result
representative of three independent experiments is shown.1341 Liu et al.
ical tolerance to self-antigens (48, 49), and since this selec-
tion depends on the threshold of intracellular signals (48,
50), deletion of the inhibitory regulator Ship may produce
a stronger signal, which exceeds the signaling threshold for
negative selection and leads to a greater reduction of bone
marrow B cells. Consistent with this hypothesis, we have
also observed a shift from IgMhiIgDhi to the more mature
IgMloIgDhi population in Ship2/2 B cells, a phenotype nor-
mally correlating with B cell hyperresponsiveness caused by
the deletion of negative regulators (51).
The enhanced proliferative response of Ship2/2 B cells
after anti-Ig stimulation and increased basal serum levels of
different Ig subclasses suggest a possible deregulation of an-
tibody production in vivo due to the disruption of an im-
mune complex–mediated inhibition. Surprisingly, the Ig
levels of neutralizing IgM and IgG after VSV infection
were comparable among Ship1/2Rag2/2 and Ship2/2Rag2/2
chimeric mice, suggesting that additional pathways for
maintaining antibody homeostasis are operating in VSV-
specific responses. Whether Ship2/2Rag2/2 chimeric mice
would respond differently to pathogenic stimulation other
than VSV remains to be determined.
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